{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T03:30:20Z","timestamp":1648870220513},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1991,9,1]],"date-time":"1991-09-01T00:00:00Z","timestamp":683683200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Nuerosci"],"published-print":{"date-parts":[[1991,9]]},"DOI":"10.1007\/bf02191152","type":"journal-article","created":{"date-parts":[[2005,9,21]],"date-time":"2005-09-21T00:25:20Z","timestamp":1127262320000},"page":"109-112","source":"Crossref","is-referenced-by-count":4,"title":["Substance P-like immunoreactivity and somatostatin-like immunoreactivity in the ventricular fluid of patients with chronic pain syndromes"],"prefix":"10.1007","volume":"241","author":[{"given":"Stefan","family":"Jost","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Reuner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Geiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mosen","family":"Mohadjer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Milios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hinrich","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02191152_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0304-3959(88)90197-2","volume":"33","author":"BGL Almay","year":"1988","unstructured":"Almay BGL, Johansson F, Knorring L von, Le Grev\u00e9s P, Terenius L (1988) Substance P in CSF of patients with chronic pain syndromes. Pain 33:3\u20139","journal-title":"Pain"},{"key":"BF02191152_CR2","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(84)92761-2","volume":"II","author":"J Chrubasik","year":"1984","unstructured":"Chrubasik J, Meynadier J, Blond S, Scherpereel P, Ackermann E, Weinstock M, Bonath K, Cramer H, W\u00fcnsch E (1984) Somatostatin, a potent analgesic. Lancet II:1208\u20131209","journal-title":"Lancet"},{"key":"BF02191152_CR3","first-page":"200","volume-title":"2nd International Symposium on Somatostatin","author":"H Cramer","year":"1984","unstructured":"Cramer H, Kohler J, Oepen G, Schroeter E (1984) Somatostatin-like immunoreactivity in the cerebrospinal fluid of neurological patients. In: Raptis S, Rosenthal J, Gerich JE (eds), 2nd International Symposium on Somatostatin. Attempto, T\u00fcbingen, pp 200\u2013203"},{"key":"BF02191152_CR4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF00313833","volume":"232","author":"H Cramer","year":"1985","unstructured":"Cramer H, Schaudt D, Rissler K, Strubel D, Warter JM, Kuntzmann F (1985a) Somatostatin-like immunoreactivity and substance P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus. J Neurol 232:346\u2013351","journal-title":"J Neurol"},{"key":"BF02191152_CR5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00313783","volume":"232","author":"H Cramer","year":"1985","unstructured":"Cramer H, Wolf A, Rissler K, Weigel K, Ostertag C (1985b) Ventricular somatostatin-like immunoreactivity in patients with basal ganglia disease. J Neurol 232:219\u2013222","journal-title":"J Neurol"},{"key":"BF02191152_CR6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0143-4179(88)90041-8","volume":"12","author":"H Cramer","year":"1988","unstructured":"Cramer H, R\u00f6sler N, Rissler K, Gagnieu MC, Renaud B (1988) Cerebrospinal fluid immunoreactive substance P and somatostatin in neurological patients with periphral and spinal cord disease. Neuropeptides 12:119\u2013124","journal-title":"Neuropeptides"},{"key":"BF02191152_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000116366","volume":"29","author":"H Cramer","year":"1989","unstructured":"Cramer H, Rissler K, R\u00f6sler N, Strubel D, Schaudt D, Kuntzmann F (1989) Immunoreactive substance P and somatostatin in the cerebrospinal fluid of senile parkinsonian patients. Eur Neurol 29:1\u20135","journal-title":"Eur Neurol"},{"key":"BF02191152_CR8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0006-8993(85)91147-3","volume":"342","author":"AM Giulio Di","year":"1985","unstructured":"Di Giulio AM, Mantegazza P, Dona M, Gorio A (1985) Peripheral nerve lesions cause simultaneous alterations of substance P and enkephalin levels in the spinal cord. Brain Res 342:405\u2013408","journal-title":"Brain Res"},{"key":"BF02191152_CR9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0006-3223(89)90196-0","volume":"25","author":"AR Doran","year":"1989","unstructured":"Doran AR, Rubinow DR, Wolkowitz OM, Roy A, Breier A, Pickar D (1989) Fluphenazine treatment reduces CSF somatostatin in patients with schizophrenia: correlations with CSF HVA. Biol Psychiatry 25:431\u2013439","journal-title":"Biol Psychiatry"},{"key":"BF02191152_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-510X(87)90073-6","volume":"78","author":"PT Francis","year":"1987","unstructured":"Francis PT, Bowen DM, Lowe SL, Neary D, Mann DMA, Snowden JS (1987) Somatostatin content and release measured in cerebral biopsies from demented patients. J Neurol Sci 78:1\u201316","journal-title":"J Neurol Sci"},{"key":"BF02191152_CR11","first-page":"611","volume":"5","author":"TM Jessell","year":"1979","unstructured":"Jessell TM, Mudge AW, Leeman SE, Yaksh TL (1979) Release of substance P and somatostatin in vivo, from primary afferent terminals in mammalian spinal cord. Proc Soc Neurosci 5:611","journal-title":"Proc Soc Neurosci"},{"key":"BF02191152_CR12","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0006-8993(85)90326-9","volume":"325","author":"Y Kuraishi","year":"1985","unstructured":"Kuraishi Y, Hirota N, Sato Y, Nino Y, Satoh M, Takagi H (1985) Evidence that substance P and somatostatin transmit separate information related to pain in the spinal dorsal horn. Brain Res 325:294\u2013298","journal-title":"Brain Res"},{"key":"BF02191152_CR13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0143-4179(81)90013-5","volume":"1","author":"F Lembeck","year":"1981","unstructured":"Lembeck F, Donnerer J, Colpaert FC (1981) Increase of substance P in primary afferent nerves during chronic pain. Neuropeptides 1:175\u2013180","journal-title":"Neuropeptides"},{"issue":"Suppl","key":"BF02191152_CR14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0304-3959(87)91355-8","volume":"4","author":"I Madrazo","year":"1987","unstructured":"Madrazo I, Franco-Bourland R, Leon V, Mena I (1987) Analgesic effect of intracerebroventricular (icv) somatostatin-14 (SOM-14), arginine vasopressin (AVP) and oxytocin (OT) in a patient with terminal cancer pain. Pain [Suppl] 4:142","journal-title":"Pain"},{"key":"BF02191152_CR15","first-page":"61","volume":"34","author":"K Masaki","year":"1987","unstructured":"Masaki K (1987) A study of B-endorphin and substance P levels in cerebrospinal fluid on lumbar lesion. Tokushima J Exp Med 34:61\u201369","journal-title":"Tokushima J Exp Med"},{"key":"BF02191152_CR16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0006-8993(85)90744-9","volume":"343","author":"VJ Massari","year":"1985","unstructured":"Massari VJ, Shults CW, Park CH, Tizabi Y, Moody TW, Chronwall BM, Culver M, Chase TN (1985) Deafferentation causes a loss of presynaptic bombesin receptors and supersensitivity of substance P receptors in the dorsal horn of the cat spinal cord. Brain Res 343:268\u2013274","journal-title":"Brain Res"},{"key":"BF02191152_CR17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0306-4522(87)90281-8","volume":"23","author":"D Menetrey","year":"1987","unstructured":"Menetrey D, Basbaum AI (1987) The distribution of substance P-, enkephalin- and dynorphin-immunoreactive neurons in the medulla of the rat and their contribution to bulbospinal pathways. Neuroscience 23:173\u2013187","journal-title":"Neuroscience"},{"key":"BF02191152_CR18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1476-5381.1984.tb10773.x","volume":"82","author":"SM Moochhala","year":"1984","unstructured":"Moochhala SM, Sawynok J (1984) Hyperalgesia produced by intrathecal substance P and related peptides. Desensitization and cross desensitization. Br J Pharmacol 82:381\u2013388","journal-title":"Br J Pharmacol"},{"key":"BF02191152_CR19","volume-title":"Stereotaktische Operationen am Gehirn","author":"F Mundinger","year":"1975","unstructured":"Mundinger F (1975) Stereotaktische Operationen am Gehirn, Hippokrates, Stuttgart"},{"key":"BF02191152_CR20","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1212\/WNL.30.12.1280","volume":"30","author":"JG Nutt","year":"1980","unstructured":"Nutt JG, Mroz EA, Leeman SE, Williams AC, Engel WK, Chase TN (1980) Substance P in human cerebrospinal fluid: reductions in peripheral neuropathy and autonomic dysfunction. Neurology 30:1280\u20131285","journal-title":"Neurology"},{"key":"BF02191152_CR21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000212476","volume":"27","author":"JJ Oram","year":"1981","unstructured":"Oram JJ, Edwardson J, Millard PH (1981) Investigations of cerebrospinal fluid neuropeptides in idiopathic senile dementia. Gerontology 27:216\u2013223","journal-title":"Gerontology"},{"key":"BF02191152_CR22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.pa.17.040177.002233","volume":"17","author":"M Otsuka","year":"1977","unstructured":"Otsuka M, Takahashi T (1977) Putative peptide neurotransmitters. Annu Rev Pharmacol Toxicol 17:425\u2013439","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BF02191152_CR23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/295061a0","volume":"295","author":"J Pearson","year":"1982","unstructured":"Pearson J, Brandeis L, Cuello AC (1982) Depletion of substance P-containing axons in substantia gelatinosa of patients with diminished pain sensitivity. Nature 295:61\u201363","journal-title":"Nature"},{"key":"BF02191152_CR24","first-page":"85","volume":"35","author":"B Pernow","year":"1983","unstructured":"Pernow B (1983) Substance P. Pharmacol Rev 35:85\u2013141","journal-title":"Pharmacol Rev"},{"key":"BF02191152_CR25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0006-8993(78)90148-8","volume":"152","author":"M Randic","year":"1978","unstructured":"Randic M, Miletic V (1978) Depressant action of methionin-enkephalin and somatostatin in cat dorsal horn neurones activated by noxious stimuli. Brain Res 152:196\u2013202","journal-title":"Brain Res"},{"issue":"Suppl","key":"BF02191152_CR26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3959(87)91462-X","volume":"4","author":"T Sakurada","year":"1987","unstructured":"Sakurada T, Kuwahara H, Sakurada S, Kisara K (1987) Nociceptive responses induced by intrathecally administered substance P and its fragments in mice. Pain [Suppl] 4:195","journal-title":"Pain"},{"key":"BF02191152_CR27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1748-1716.1988.tb08517.x","volume":"134","author":"M Schalling","year":"1988","unstructured":"Schalling M, Arborelius L, H\u00f6kfelt T, Post C (1988) Decrease in gene expression of substance P and thyrotropin releasing hormone (TRH) in rat medulla oblongata following treatment with an antidepressive drug. Acta Physiol Scand 134:455\u2013456","journal-title":"Acta Physiol Scand"},{"key":"BF02191152_CR28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0404.1986.tb04640.x","volume":"74","author":"K Steardo","year":"1986","unstructured":"Steardo K, Barone P, Hunnicutt E (1986) Carbamazepin lowering effect on CSF somatostatin-like immunoreactivity in temporal lobe epileptics. Acta Neurol Scand 74:140\u2013144","journal-title":"Acta Neurol Scand"},{"key":"BF02191152_CR29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0304-3959(88)90087-5","volume":"33","author":"BJ Urban","year":"1988","unstructured":"Urban BJ, France RD, Bissette G, Spielmann FJ, Nemeroff CB (1988) Alterations in cerebrospinal fluid concentrations of somatostatin-like immunoreactivity in chronic pain patients. Pain 33:169\u2013172","journal-title":"Pain"},{"key":"BF02191152_CR30","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0006-8993(86)91473-3","volume":"372","author":"Z Wiesenfeld-Hallin","year":"1986","unstructured":"Wiesenfeld-Hallin Z (1986) Substance P and somatostatin modulate spinal cord excitability via physiologically different sensory pathways. Brain Res 372:172\u2013175","journal-title":"Brain Res"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02191152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02191152\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02191152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T13:33:43Z","timestamp":1557840823000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02191152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,9]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1991,9]]}},"alternative-id":["BF02191152"],"URL":"https:\/\/doi.org\/10.1007\/bf02191152","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,9]]}}}